Longer leukocyte telomere length associated with better cardiac function and lower risk of incident HF: JAMA
Written By : Aditi
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2023-08-12 05:00 GMT | Update On 2023-08-12 06:40 GMT
Advertisement
An Original Investigation published on July 26, 2023, in JAMA Cardiology entitled "Association of Longer Leukocyte Telomere Length With Cardiac Size, Function, and Heart Failure" by Dr Nay Aung and colleagues has highlighted there is a role of modulation of leukocyte telomere length or LTL dynamics in improving cardiovascular structure and function.
There is an association between LTL and a lower risk of adverse cardiovascular outcomes. There needs to be more clarity on the extent to which LTL variation is associated with intermediary cardiovascular phenotypes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.